Dyne Therapeutics (DYN) Stock Insights

DYN price $16.98 +0.04 +0.24%

Ticker
DYN
Price
$16.98
Change
+0.04 +0.24%
Market cap ?
$3.17B
P/E ?
-4.92
Forward P/E ?
34.75
Dividend yield ?
0.00%
Beta ?
1.12
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
69
Value
55
Quality
53
Growth
100

Stocklytics score rationale: value 55, quality 53, growth 100.

Financials

2016201720182019202020212022202320242025
136600000050600000000000000

Dyne Therapeutics, Inc. is a U.S.-based biotechnology firm focused on developing advanced treatments for genetically driven muscle disorders. Utilizing its proprietary FORCE platform, which is engineered to deliver disease-modifying therapeutics, the company is actively engaged in various programs. These initiatives target conditions such as myotonic dystrophy type 1, Duchenne muscular dystrophy, and…

Fair value

DYN fair value $14.94. Price $16.98. Price is 14% above fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 32.37M. Growth 0.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 10.46% (beta 1.1). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 186.75M. Net debt -873.09M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Compare DYN

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-04—-0.91——
2026-07-30-1.08-0.75——
2026-05-11-0.73-0.77——
2026-03-02-0.76-0.74——
2025-11-05-0.76-0.81——
2025-07-28-0.97-0.99——
2025-05-08-1.05-0.88——
2025-02-27-0.88-0.92——
2024-11-12-0.96-0.71——
2024-08-12-0.70-0.72——
2024-05-02-0.81-0.81—1.67M
2024-03-05-1.09-0.923.79M—
2023-10-30-0.99-0.86——
2023-08-03-1.08-0.81——
2023-05-11-0.78-0.77——
2023-03-02-0.74-0.84——
2022-11-03-0.80-0.95——
2022-08-04-1.01-0.79——
2022-05-02-0.69-0.88——
2022-03-10-1.00-0.99——
2021-11-04-0.83-0.65——
2021-08-05-0.58-0.55——
2021-05-06-0.50-0.60——
2021-03-04-0.64-0.38——
2020-11-05-2.01-0.87——
2020-09-17-0.62———
2020-06-30-0.22———
2019-12-31-0.42———
2019-09-30-0.46———
2019-06-30-0.76———
2019-03-31-0.76———
2018-02-22-8.71—470.00M—
2017-11-01-0.82—182.00M—
2017-08-04-1.83—181.00M—
2017-05-053.69—175.00M—
2017-02-24-1.41—791.00M—
2016-11-02-1.98—241.00M—
2016-08-04-6.81—166.00M—
2016-05-04-0.08—168.00M—
2016-02-25-1.06—217.00M—

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-20Kerr DouglasBuy8.00K——
2026-10-20Kerr DouglasBuy12.00K$16.27195.24K
2026-10-02Posner Brian SBuy2.50K$16.0040.00K
2026-09-08Friedl-Naderer JohannaSell185$18.883.49K
2026-09-08Kerr DouglasSell1.29K$18.8824.36K
2026-09-08Cox JohnSell5.66K$18.88106.82K
2026-09-04Friedl-Naderer JohannaSell900$24.3521.91K
2026-09-04Kerr DouglasSell3.75K$24.3591.19K
2026-08-14Rhodes Jason PSell1.36M$25.0033.99M
2026-08-14Rhodes Jason PSell478.38K$25.0011.96M
2026-08-14Rhodes Jason PSell322.46K$25.008.06M
2026-08-13Rhodes Jason PSell268.35K$26.207.03M
2026-08-13Rhodes Jason PSell94.42K$26.202.47M
2026-08-13Rhodes Jason PSell63.64K$26.201.67M
2026-08-13Friedl-Naderer JohannaSell226$26.285.94K
2026-08-13Kerr DouglasSell1.56K$26.2840.89K
2026-08-13Cox JohnSell4.99K$26.28131.03K
2026-08-13Lucera ErickSell1.80K$26.2847.23K
2026-07-27Kersten DirkSell256.07K$25.506.53M
2026-07-27Kersten DirkSell5.39K$26.04140.32K
2026-07-07Rhodes Jason PSell124.38K$23.172.88M
2026-07-07Rhodes Jason PSell29.59K$23.62698.84K
2026-07-07Rhodes Jason PSell62.54K$23.171.45M
2026-07-07Rhodes Jason PSell14.84K$23.62350.62K
2026-07-07Rhodes Jason PSell49.19K$23.171.14M
2026-07-07Rhodes Jason PSell11.66K$23.62275.53K
2026-07-07Rhodes Jason PSell5.00K$23.61118.05K
2026-07-06Rhodes Jason PSell253.04K$22.795.77M
2026-07-06Rhodes Jason PSell127.18K$22.792.90M
2026-07-06Rhodes Jason PSell100.02K$22.792.28M
2026-06-29Rhodes Jason PSell102.97K$21.142.18M
2026-06-29Rhodes Jason PSell51.76K$21.141.09M
2026-06-29Rhodes Jason PSell40.70K$21.14860.44K
2026-06-26Rhodes Jason PSell162.95K$21.283.47M
2026-06-26Rhodes Jason PSell81.90K$21.281.74M
2026-06-26Rhodes Jason PSell64.41K$21.281.37M
2026-06-25Lucera ErickSell2.36K$20.3748.11K
2026-06-25Rhodes Jason PSell12.70K$21.10267.95K
2026-06-25Rhodes Jason PSell6.38K$21.10134.66K
2026-06-25Rhodes Jason PSell5.02K$21.10105.90K
2026-06-24Rhodes Jason PSell50.53K$21.021.06M
2026-06-24Rhodes Jason PSell25.40K$21.02533.84K
2026-06-24Rhodes Jason PSell19.97K$21.02419.83K
2026-06-23Rhodes Jason PSell77.86K$21.131.65M
2026-06-23Rhodes Jason PSell39.13K$21.13826.84K
2026-06-23Rhodes Jason PSell30.77K$21.13650.25K
2026-06-23Kersten DirkSell71.63K$21.041.51M
2026-06-23Kersten DirkSell1.66K$21.4735.58K
2026-06-22Kersten DirkSell190.68K$20.573.92M
2026-06-22Greene Barry EBuy57.46K$20.871.20M
2026-06-22Greene Barry EOther0——
2026-06-18Kersten DirkSell46.90K$20.07941.37K
2026-06-17Kersten DirkSell37.45K$20.14754.32K
2026-06-16Kerr DouglasSell887$18.3316.26K
2026-06-16Friedl-Naderer JohannaSell145$18.332.66K
2026-06-16Cox JohnSell2.68K$18.3349.18K
2026-06-08Posner Brian SBuy2.00K$16.9433.88K
2026-06-05HURWITZ EDWARDBuy35.15K$17.04598.99K
2026-06-05Lubner David CharlesBuy35.15K$17.04598.99K
2026-06-05Rhodes Jason PBuy35.15K$17.04598.99K
2026-06-05Kersten DirkBuy35.15K$17.04598.99K
2026-06-05Incerti CarloBuy35.15K$17.04598.99K
2026-06-05Stehman-Breen CatherineBuy35.15K$17.04598.99K
2026-06-05Posner Brian SBuy35.15K$17.04598.99K
2026-06-03Posner Brian SBuy2.50K$17.4843.70K
2026-05-26Posner Brian SBuy2.00K$18.2136.42K
2026-05-20Posner Brian SBuy2.50K$17.1242.80K
2026-05-13Friedl-Naderer JohannaSell228$18.364.19K
2026-05-13Kerr DouglasSell1.56K$18.3628.72K
2026-05-13Lucera ErickSell1.45K$18.3626.59K
2026-05-13Cox JohnSell3.31K$18.3660.79K
2026-05-06Rhodes Jason PSell43.62K$18.18793.03K
2026-05-06Rhodes Jason PSell21.93K$18.18398.61K
2026-05-06Rhodes Jason PSell17.24K$18.18313.50K
2026-05-06Rhodes Jason PSell428$18.187.78K
2026-05-05Rhodes Jason PSell6.08K$18.03109.64K
2026-05-05Rhodes Jason PSell3.06K$18.0355.10K
2026-05-05Rhodes Jason PSell2.40K$18.0343.33K
2026-05-05Rhodes Jason PSell60$18.031.08K
2026-05-04Rhodes Jason PSell6.24K$18.00112.34K
2026-05-04Rhodes Jason PSell3.14K$18.0056.45K
2026-05-04Rhodes Jason PSell2.47K$18.0044.39K
2026-05-04Rhodes Jason PSell61$18.001.10K
2026-04-28Rhodes Jason PSell119.11K$18.382.19M
2026-04-28Rhodes Jason PSell52$19.00988
2026-04-28Rhodes Jason PSell59.87K$18.381.10M
2026-04-28Rhodes Jason PSell26$19.00494
2026-04-28Rhodes Jason PSell47.08K$18.38865.37K
2026-04-28Rhodes Jason PSell21$19.00399
2026-04-28Rhodes Jason PSell1.17K$18.3821.50K
2026-04-28Rhodes Jason PSell1$19.0019
2026-04-27Rhodes Jason PSell90.94K$18.151.65M
2026-04-27Rhodes Jason PSell45.71K$18.15829.62K
2026-04-27Rhodes Jason PSell35.95K$18.15652.44K
2026-04-27Rhodes Jason PSell894$18.1516.23K
2026-04-24Lubner David CharlesSell53.62K——
2026-04-24Rhodes Jason PSell72.31K$18.481.34M
2026-04-24Rhodes Jason PSell36.34K$18.48671.66K
2026-04-24Rhodes Jason PSell28.58K$18.48528.21K
2026-04-24Rhodes Jason PSell710$18.4813.12K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 254, holders +18 vs prior quarter. Ownership 116.23%.

HolderSharesChangeChange %Value
T. ROWE PRICE INVESTMENT MANAGEMENT, INC.30.91M126.49K+0.41%686.56M
BLACKROCK, INC.12.40M704.46K+6.02%275.50M
JUPITER TOPCO LLC12.00M12.00MNew266.63M
FMR LLC11.21M2.30M+25.79%248.91M
STATE STREET CORP7.46M804.52K+12.09%165.65M
ORBIS ALLAN GRAY LTD7.01M244.31K+3.61%155.62M
ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC6.80M-2.33M-25.52%151.03M
VANGUARD CAPITAL MANAGEMENT LLC6.31M-94.10K-1.47%140.17M
TCG CROSSOVER MANAGEMENT, LLC4.62M00.00%102.50M
VANGUARD PORTFOLIO MANAGEMENT LLC4.05M-113.61K-2.73%89.92M
PRICE T ROWE ASSOCIATES INC /MD/3.94M1.61M+69.08%87.44M
FCPM III SERVICES B.V.3.85M-796.13K-17.14%85.47M
GEODE CAPITAL MANAGEMENT, LLC3.74M239.31K+6.83%83.16M
VESTAL POINT CAPITAL, LP3.38M-625.00K-15.62%74.96M
ORBIMED ADVISORS LLC3.24M317.80K+10.89%71.86M
FRAZIER LIFE SCIENCES MANAGEMENT, L.P.3.15M00.00%70.03M
ARMISTICE CAPITAL, LLC3.09M-87.88K-2.77%68.57M
JPMORGAN CHASE & CO3.15M-101.82K-3.13%67.15M
PERCEPTIVE ADVISORS LLC2.69M-1.98M-42.40%59.73M
LOGOS GLOBAL MANAGEMENT LP2.55M1.15M+82.14%56.64M
BANK OF AMERICA CORP /DE/2.23M790.09K+54.74%49.60M
VENROCK ADVISER, LLC2.17M00.00%48.28M
GOLDMAN SACHS GROUP INC2.16M434.08K+25.19%47.91M
SIREN, L.L.C.2.13M-100.00K-4.49%47.29M
FRANKLIN TEMPLETON INC2.03M21.74K+1.08%45.10M

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Dyne Therapeutics (DYN) Stock Insights

DYN$16.98+0.04 +0.24%

$3.17B

Market Cap

-4.92

P/E

34.75

Forward P/E

69

Score

Price History